| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $178.9M | $196.4M | $230.1M |
| YoY Revenue Growth % | -8.9% | -14.6% | — |
| Gross Profit | $31.4M | $38.7M | — |
| Gross Margin % | 17.6% | 19.7% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$35.9M | -$26.0M | -$57.6M |
| Operating Margin % | -20.0% | -13.2% | -25.1% |
| Net Income (GAAP) | -$29.7M | -$54.3M | -$36.6M |
| EBITDA (Normalized) | -$11.9M | -$16.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$24.2M | -$6.1M | -$3.0M |
| Capital Expenditures (CapEx) | $30.0M | $11.6M | — |
| Free Cash Flow (FCF) | -$54.2M | -$17.7M | -$3.0M |
| FCF Margin % | -30.3% | -9.0% | -1.3% |
| Return on Invested Capital (ROIC %) | -15.0% | -12.4% | — |
| Cash & Short-Term Equivalents | $103.8M | $138.6M | — |
| Total Debt (Short + Long Term) | $44.6M | $27.2M | — |
| Total Stockholders' Equity | $248.3M | $276.8M | — |